English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduMount Sinai-led study is the first to show there are no sex disparities in patient outcomes with this new technology
Tag: Icahn School of Medicine at Mount Sinai
Largest Brain Autopsy Study of Female Intimate Partner Violence Decedents Reveals Brain Injury Pathology Unlike That Seen Among Male Contact Sports Athletes
The largest brain autopsy study of women who had experienced intimate partner violence reveals substantial vascular and white matter damage in the brain, but no evidence of chronic traumatic encephalopathy (CTE), the neurodegenerative disease recognized among male contact sports athletes who sustain repeated head trauma.
Mount Sinai Receives $4.6 Million From The Pershing Square Foundation to Support Women’s Health Research and Careers for Women in Science
The Icahn School of Medicine at Mount Sinai has received a $4.6 million gift from The Pershing Square Foundation to support women’s health research and advance careers for female scientists
Certain Per- and Polyfluoroalkyl “Forever Chemicals” Identified as Potential Risk Factor for Thyroid Cancer
Mount Sinai researchers have discovered a link between certain per- and polyfluoroalkyl substances (PFAS) and an increased risk for thyroid cancer.
Oula Announces Third Clinic And Expanded Partnership With Mount Sinai Health System To Provide Wider Access To Collaborative Maternity Care
Oula-Mount Sinai West partnership offers patients the best of obstetrics and midwifery, with midwife-led delivery supported by leading hospital’s expertise and resources
CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing
CastleVax, a clinical stage vaccine platform company, has received a Project NexGen award valued at up to $338 million from the Biomedical Advanced Research and Development Authority (BARDA), to support the development of a next-generation, booster vaccine to protect against COVID-19 for years to come.
Mount Sinai Announces Partnership With the Chiba Institute of Technology in Japan Focusing on Artificial Intelligence to Transform Cardiovascular Research
Agreement aims to help make clinical trials more efficient and lead to faster advances in patient care
Mount Sinai Rehabilitation Centers Ranked Among the Best in the United States by Newsweek
Top rankings include Mount Sinai Morningside and The Mount Sinai Hospital, with stroke rehabilitation a standout program
People with Long COVID Have Distinct Hormonal and Immune Differences From Those Without This Condition
Research conducted at Mount Sinai and Yale confirms long COVID is a biological disease by showing blood biomarkers that can predict who has it
Decoding Depression: Researchers Identify Crucial Biomarker That Tracks Recovery From Treatment-Resistant Depression
A team of leading clinicians, engineers, and neuroscientists has made a groundbreaking discovery in the field of treatment-resistant depression.
Certain Community Health Care Worker Programs Often Exploit Volunteers, Mount Sinai Researchers Report
First systematic study of the subject finds that more than half of unsalaried community health care workers in dual-cadre programs experienced unfair treatment in the workplace
Preschoolers From Low-Income Families May Have Worse Health and Benefit Less From Health Promotion Interventions Than Children With Higher Socioeconomic Status
Mount Sinai study focused on Harlem preschools emphasizes the need for specialized health promotion programs in classrooms starting at an early age
Mount Sinai Researchers Develop Novel, Automated Measure of Sleep Studies to Determine Severity of Obstructive Sleep Apnea
New method can predict risks of cardiovascular disease, mortality in sleep apnea patients
Mount Sinai Announces Partnership With the Brazilian Clinical Research Institute to Advance Cardiovascular Disease Research and Medical Education
Agreement aims to improve patient care and outcomes on a global scale
Optical Coherence Tomography May Improve Safety and Outcomes for Stenting Procedures in Heart Disease Patients Compared to Conventional Angiography
Results from a large-scale clinical trial results could increase usage of high resolution imaging for guiding interventional coronary procedures
Mount Sinai Study Identifies Most Effective and Safest Outpatient Labor Induction Methods, Potentially Reducing Hospital Stays and Increasing Hospital Efficiency in Use of Resources
Mount Sinai study identifies most effective and safest outpatient labor induction methods, potentially reducing hospital stays and increasing hospital efficiency in use of resources
Mount Sinai Receives Significant Funding to Study Which Coronary Revascularization Procedure Best Improves Survival and Quality of Life for Women and Underserved Minority Groups
The Icahn School of Medicine at Mount Sinai will help lead and launch the first clinical trial focusing on women and minority populations to determine which coronary revascularization procedure best improves their survival and quality of life.
Father’s Psychiatric Diagnosis Increases Risk of Preterm Birth, Study Reports
Babies are more likely to be born prematurely when either their father or mother has had a psychiatric diagnosis, according to a study.
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission
The Icahn School of Medicine at Mount Sinai in New York, NY is pleased to announce that CastleVax, Inc. has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus (NDV)-based COVID-19 booster vaccine.
Study Shows Differences in How Patients With Heroin Use Disorder Process Drug and Reward Cues
Findings may help inform the development of intervention and prevention strategies
Mount Sinai Participates in $40 Million Multisite Study of Alzheimer’s Disease in Asian Americans and Asian Canadians
Study represents a major milestone toward health equity for underrepresented populations in Alzheimer’s disease research
Mount Sinai Launches Center for Ophthalmic Artificial Intelligence and Human Health
The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.
Mount Sinai Patients Receive Greater and Faster Access to Care With New Expanded Digital Tools
Mount Sinai Health System patients will experience greater access to care, fast identification of symptoms, efficient online search and connection to specialists, and easy appointment scheduling thanks to newly launched Digital Experience tools accessible on their smartphones or computers.
Patients With Specific Types of Lipids May Be at Higher Risk of Developing Blinding Eye Disease
Principal Investigator: Louis R. Pasquale, MD, FARVO, Deputy Chair for Ophthalmology Research for the Mount Sinai Health System Co-First Authors: Oana A. Zeleznik, PhD, Instructor in Medicine at Brigham and Women’s Hospital and Jae H. Kang, ScD, Assistant Professor of…
Mount Sinai Experts Present Research at SLEEP 2023
Sleep medicine experts from the Mount Sinai Health System are presenting new research at SLEEP 2023, the 37th annual meeting of the Associated Professional Sleep Societies running until June 7 in Indianapolis.
Mount Sinai Researchers Identify Potential New Treatment for Those Who Act Out Their Dreams While Sleeping
Experts say medication commonly used to treat insomnia may also be a therapeutic option for the condition known as REM sleep behavior disorder
George Dangas, MD, PhD, Named President of Society for Cardiovascular Angiography & Interventions
First Mount Sinai cardiologist to hold this prestigious position
Researchers Show That a Machine Learning Model Can Improve Mortality Risk Prediction for Cardiac Surgery Patients
A machine learning-based model that enables medical institutions to predict the mortality risk for individual cardiac surgery patients has been developed by a Mount Sinai research team, providing a significant performance advantage over current population-derived models.
Coronary Bioresorbable Scaffolds Nearly as Safe and Effective as Conventional Metal Stents for Heart Disease Patients
First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing percutaneous coronary intervention (PCI).
Mount Sinai Launches Institute for Regenerative Medicine
Institute, including three new centers, will lead research to foster novel discoveries and explore new treatments for a range of diseases from leukemia to Alzheimer’s disease.
Mount Sinai Awarded Prestigious $1.3 Million Grant to Expand Research Training Program in Skin Biology
The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai will expand its research training program in skin biology with support from a five-year, $1.3 million T32 grant from the National Institutes of Health (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
NYC Mayor Eric Adams Joined Top Biomedical Researchers to Usher in the Center for Engineering and Precision Medicine at Hudson Research Center at 619 West 54th Street
The grand opening of the Center for Engineering and Precision Medicine (CEPM), a partnership between Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai), was held March 29, 2023 at the Hudson Research Center (HRC) at 619 West 54th Street. The center is the latest in a 10+ year partnership between RPI, a world-renowned technological research university known for its engineering, technology, and science programs, and Icahn Mount Sinai, the academic arm of the Mount Sinai Health System, which includes eight hospitals and a vast network of ambulatory practices throughout the greater New York City region.
Mount Sinai Launches Program to Increase Career Advancement Opportunities for Black Men
The Mount Sinai Health System has announced the Growth in Operations, Administrations, and Leadership Society (GOALS), an initiative to increase the representation of Black men at the middle and upper levels of management by creating pathways for career advancement through networking, mentorship, and advancement opportunities. This initiative furthers Mount Sinai’s continuing commitment to growing a diverse workplace and providing equitable care for patients.
Mount Sinai Experts Present New Research at 70th Annual Meeting of the Society for Reproductive Investigation
Reproductive health experts from the Mount Sinai Health System are presenting research at the 70th Annual Meeting of the Society for Reproductive Investigation (SRI) in Brisbane, Australia from March 21-25.
Mount Sinai Collaborates with The New York Public Library to Support Telehealth Access and Digital Literacy Skills
In an effort to expand equitable health care throughout New York City, the Digital and Technology Partners (DTP) department at Mount Sinai Health System is collaborating with The New York Public Library (NYPL) to support access to health services through electronic information or technologies—better known as telehealth—and digital literacy skills.
A Novel Mechanism May Be Effective in Patients With Severe Hypertriglyceridemia and Prior Episodes of Acute Pancreatitis
A novel type of therapy, known as ANGPTL3 inhibitor therapy, was effective in lowering triglycerides in certain types of patients with severe hypertriglyceridemia (sHTG) who had a prior episode(s) of acute pancreatitis. sHTG is a well-established risk factor for recurrent episodes of acute pancreatitis. These high-risk patients were the focus of a phase 2 study that was led by the Icahn School of Medicine at Mount Sinai and sponsored and funded by Regeneron.
High-Dose Anticoagulation Can Reduce Intubations and Improve Survival for Hospitalized COVID-19 Patients
High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is low-dose anticoagulation.
Transcatheter Mitral Valve Repair in Heart Failure Patients Significantly Reduces Hospitalizations and Improves Survival
Breakthrough findings from study led by Mount Sinai researcher could improve outcomes for high-risk patients
Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children
Mount Sinai Health System and Memorial Sloan Kettering Cancer Center researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery of anti-cancer drugs to treat brain tumors in children.
First Stem Cells From a Bat Species Known to Harbor SARS-CoV-2 Could Shed Light on Virus Survival and Molecular Adaptability
Researchers from the Icahn School of Medicine at Mount Sinai have generated the first induced pluripotent stem cells (iPSCs) from bats, gaining valuable insights into the close relationship between bats and viruses.
How AI Can Help Design Drugs to Treat Opioid Addiction
ROCKVILLE, MD – Approximately three million Americans suffer from opioid use disorder, and every year more than 80,000 Americans die from overdoses. Opioid drugs, such as heroin, fentanyl, oxycodone and morphine, activate opioid receptors. Activating mu-opioid receptors leads to pain relief and euphoria, but also physical dependence and decreased breathing, the latter leading to death in the case of drug overdose.
Mount Sinai’s Arnhold Institute for Global Health Awarded $8 Million to Expand Global Partnerships in Education and Research
The Arnhold Institute for Global Health at Mount Sinai has received $8 million from the Arnhold Foundation, enabling doctors, researchers, and students to advance its already-strong base of clinical education programs, training, research, and care services to address the world’s leading health issues and improve global health systems.
Cocaine Use Disorder Alters Gene Networks of Neuroinflammation and Neurotransmission in Humans
Analysis reveals similar changes in the brain’s functioning in both humans and mouse models
Mount Sinai Researchers Identify Functions of Muscle Surrounding Hair Follicles That Cause Hair Regression
MEDIA ADVISORY UNDER EMBARGO UNTIL 11:00AM ET, MONDAY, JANUARY 30, 2023 Paper Title: Progenitor-derived endothelin controls dermal sheath contraction for hair follicle regression Journal: Nature Cell Biology (January 30, 2023) Authors: Michael Rendl, MD, Professor of Cell, Developmental and Regenerative Biology,…
Learn CPR and Lower Your Stress: Mount Sinai Cardiologists Emphasize Their Importance During American Heart Month
Doctors warn about lack of knowledge of administering CPR, especially in high-risk groups, and the rise of stress-related heart issues
Michael E. Farkouh, MD, MSc, Named Associate Dean for Research and Clinical Trials
Cedars-Sinai has appointed Michael E. Farkouh, MD, MSc, as associate dean for Research and Clinical Trials and professor of Cardiology, effective March 1, 2023. A clinical cardiologist and epidemiologist, Farkouh is internationally known for his academic leadership and distinguished record of diabetes and cardiovascular disease clinical trials.
Mount Sinai Researchers First to Identify That Two Separate Eye Diseases May Contribute to Common Blinding Eye Condition
Two separate eye diseases may contribute to age-related macular degeneration (AMD), a leading cause of blindness in the United States, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.
Cedars-Sinai Comprehensive Transplant Center Welcomes New Faculty
Peter Heeger, MD, Justin Steggerda, MD, Hirsh Trivedi, MD, and Lorenzo Zaffiri, MD, PhD, have all recently joined the Cedars-Sinai Comprehensive Transplant Center.
Researchers Leverage Pathogen “Fingerprints” in Blood to Accelerate Infection Diagnosis
MEDIA ADVISORY UNDER EMBARGO UNTIL DECEMBER 21, 2022 in Cell Systems Corresponding Authors: Elena Zaslavsky, PhD, Associate Professor of Neurology, Icahn School of Medicine at Mount Sinai; Steven H. Kleinstein, PhD, Anthony Brady Professor of Pathology at Yale School of…
Mount Sinai Study Links Molecular Changes to Long COVID a Year After Hospitalization
Study is one of the first to associate long COVID symptoms with changes in gene expression during acute COVID-19